Concomitant medications in patients with metastatic urothelial carcinoma receiving enfortumab vedotin: real-world data from the ARON-2EV study.
Saved in:
| Title: | Concomitant medications in patients with metastatic urothelial carcinoma receiving enfortumab vedotin: real-world data from the ARON-2EV study. |
|---|---|
| Authors: | Fiala O; Department of Oncology and Radiotherapeutics, Faculty of Medicine and University Hospital in Pilsen, Charles University Prague, Alej Svobody 80, 304 60, Pilsen, Czech Republic. fialao@fnplzen.cz.; Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic. fialao@fnplzen.cz., Buti S; Medical Oncology Unit, University Hospital of Parma, Parma, Italy.; Department of Medicine and Surgery, University of Parma, Parma, Italy., Fujita K; Department of Urology, Kindai University Faculty of Medicine, Osaka, Japan., de Liaño AG; Department of Medical Oncology, Complejo Hospitalario Universitario Insular-Materno Infantil, Las Palmas, Spain., Fukuokaya W; Department of Urology, The Jikei University School of Medicine, 3-19-18 Nishi-Shimbashi, Minato-Ku, Tokyo, 105-8471, Japan., Kimura T; Department of Urology, The Jikei University School of Medicine, 3-19-18 Nishi-Shimbashi, Minato-Ku, Tokyo, 105-8471, Japan., Yanagisawa T; Department of Urology, The Jikei University School of Medicine, 3-19-18 Nishi-Shimbashi, Minato-Ku, Tokyo, 105-8471, Japan., Giannatempo P; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale Dei Tumori, Via Giacomo Venezian 1, Milan, Italy., Angel M; Clinical Oncology, Genitourinary Oncology Unit, Alexander Fleming Institute, Buenos Aires, Argentina., Mennitto A; Department of Medical Oncology, Azienda Ospedaliera Universitaria 'Maggiore Della Carit', Novara, Italy., Molina-Cerrillo J; Department of Medical Oncology, Hospital Ramón y Cajal, Madrid, Spain., Bourlon MT; Department of Hemato-Oncology, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Escuela de Medicina, Mexico-Universidad Panamericana, Mexico City, Mexico., Soares A; Hospital Israelita Albert Einstein, São Paulo, SP, Brazil.; Latin American Cooperative Oncology Group-LACOG, Porto Alegre, Brazil., Takeshita H; Department of Urology, Saitama Medical Center, Saitama Medical University, Saitama, Japan., Calabrò F; Medical Oncology 1-IRCCS Regina Elena National Cancer Institute, Rome, Italy., Ortega C; Dipartimento di Oncologia, Ospedale Michele E Pietro Ferrero-Verduno (CN) ASLCN2 Alba E, Bra, Italy., Kucharz J; Department of Uro-Oncology, Maria Sklodowska-Curie National Research Institute of Oncology Warsaw, Warsaw, Poland., Milella M; Section of Innovation Biomedicine-Oncology Area, Department of Engineering for Innovation Medicine (DIMI), University and Hospital Trust (AOUI) of Verona, 37134, Verona, Italy., Seront E; Department of Medical Oncology, Cliniques Universitaires Saint-Luc, Brussels, Belgium., Park SH; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea., Tural D; Department of Medical Oncology, Koc University Medical Faculty, Istanbul, Türkiye., Benedetti G; U.O. Oncologia, Ospedale Di Civitanova Marche, Civitanova Marche, Italy., Ürün Y; Department of Medical Oncology, Ankara University Faculty of Medicine, 06620, Ankara, Türkiye., Battelli N; Medical Oncology Unit, Macerata Hospital, Macerata, Italy., Melichar B; Department of Oncology, Faculty of Medicine and Dentistry, Palacký University, Olomouc, Czech Republic., Poprach A; Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, 656 53, Brno, Czech Republic.; Department of Comprehensive Cancer Care, Faculty of Medicine, Masaryk University, 625 00, Brno, Czech Republic., Buchler T; Department of Oncology, Second Faculty of Medicine, Charles University and Motol University Hospital, V Úvalu 84, 150 06, Prague, Czech Republic., Kopecký J; Department of Oncology, University Hospital in Hradec Králové, Sokolská 581, 50005, Hradec Králové, Czech Republic., Conteduca V; Unit of Medical Oncology and Biomolecular Therapy, Department of Medical and Surgical Sciences, University of Foggia, Policlinico Riuniti, Foggia, Italy., Monteiro FSM; Latin American Cooperative Oncology Group-LACOG, Porto Alegre, Brazil.; Hospital Sírio-Libanês, Brasília, DF, Brazil., Massari F; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria Di Bologna, Bologna, Italy.; Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy., Gupta S; Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Santoni M; Medical Oncology Unit, Macerata Hospital, Macerata, Italy. |
| Source: | Clinical & experimental metastasis [Clin Exp Metastasis] 2025 Feb 20; Vol. 42 (2), pp. 18. Date of Electronic Publication: 2025 Feb 20. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Kluwer Academic Publishers Country of Publication: Netherlands NLM ID: 8409970 Publication Model: Electronic Cited Medium: Internet ISSN: 1573-7276 (Electronic) Linking ISSN: 02620898 NLM ISO Abbreviation: Clin Exp Metastasis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39976819 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Concomitant medications in patients with metastatic urothelial carcinoma receiving enfortumab vedotin: real-world data from the ARON-2<superscript>EV</superscript> study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Fiala+O%22">Fiala O</searchLink>; Department of Oncology and Radiotherapeutics, Faculty of Medicine and University Hospital in Pilsen, Charles University Prague, Alej Svobody 80, 304 60, Pilsen, Czech Republic. fialao@fnplzen.cz.; Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic. fialao@fnplzen.cz.<br /><searchLink fieldCode="AU" term="%22Buti+S%22">Buti S</searchLink>; Medical Oncology Unit, University Hospital of Parma, Parma, Italy.; Department of Medicine and Surgery, University of Parma, Parma, Italy.<br /><searchLink fieldCode="AU" term="%22Fujita+K%22">Fujita K</searchLink>; Department of Urology, Kindai University Faculty of Medicine, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22de+Liaño+AG%22">de Liaño AG</searchLink>; Department of Medical Oncology, Complejo Hospitalario Universitario Insular-Materno Infantil, Las Palmas, Spain.<br /><searchLink fieldCode="AU" term="%22Fukuokaya+W%22">Fukuokaya W</searchLink>; Department of Urology, The Jikei University School of Medicine, 3-19-18 Nishi-Shimbashi, Minato-Ku, Tokyo, 105-8471, Japan.<br /><searchLink fieldCode="AU" term="%22Kimura+T%22">Kimura T</searchLink>; Department of Urology, The Jikei University School of Medicine, 3-19-18 Nishi-Shimbashi, Minato-Ku, Tokyo, 105-8471, Japan.<br /><searchLink fieldCode="AU" term="%22Yanagisawa+T%22">Yanagisawa T</searchLink>; Department of Urology, The Jikei University School of Medicine, 3-19-18 Nishi-Shimbashi, Minato-Ku, Tokyo, 105-8471, Japan.<br /><searchLink fieldCode="AU" term="%22Giannatempo+P%22">Giannatempo P</searchLink>; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale Dei Tumori, Via Giacomo Venezian 1, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Angel+M%22">Angel M</searchLink>; Clinical Oncology, Genitourinary Oncology Unit, Alexander Fleming Institute, Buenos Aires, Argentina.<br /><searchLink fieldCode="AU" term="%22Mennitto+A%22">Mennitto A</searchLink>; Department of Medical Oncology, Azienda Ospedaliera Universitaria 'Maggiore Della Carit', Novara, Italy.<br /><searchLink fieldCode="AU" term="%22Molina-Cerrillo+J%22">Molina-Cerrillo J</searchLink>; Department of Medical Oncology, Hospital Ramón y Cajal, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Bourlon+MT%22">Bourlon MT</searchLink>; Department of Hemato-Oncology, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Escuela de Medicina, Mexico-Universidad Panamericana, Mexico City, Mexico.<br /><searchLink fieldCode="AU" term="%22Soares+A%22">Soares A</searchLink>; Hospital Israelita Albert Einstein, São Paulo, SP, Brazil.; Latin American Cooperative Oncology Group-LACOG, Porto Alegre, Brazil.<br /><searchLink fieldCode="AU" term="%22Takeshita+H%22">Takeshita H</searchLink>; Department of Urology, Saitama Medical Center, Saitama Medical University, Saitama, Japan.<br /><searchLink fieldCode="AU" term="%22Calabrò+F%22">Calabrò F</searchLink>; Medical Oncology 1-IRCCS Regina Elena National Cancer Institute, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Ortega+C%22">Ortega C</searchLink>; Dipartimento di Oncologia, Ospedale Michele E Pietro Ferrero-Verduno (CN) ASLCN2 Alba E, Bra, Italy.<br /><searchLink fieldCode="AU" term="%22Kucharz+J%22">Kucharz J</searchLink>; Department of Uro-Oncology, Maria Sklodowska-Curie National Research Institute of Oncology Warsaw, Warsaw, Poland.<br /><searchLink fieldCode="AU" term="%22Milella+M%22">Milella M</searchLink>; Section of Innovation Biomedicine-Oncology Area, Department of Engineering for Innovation Medicine (DIMI), University and Hospital Trust (AOUI) of Verona, 37134, Verona, Italy.<br /><searchLink fieldCode="AU" term="%22Seront+E%22">Seront E</searchLink>; Department of Medical Oncology, Cliniques Universitaires Saint-Luc, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Park+SH%22">Park SH</searchLink>; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.<br /><searchLink fieldCode="AU" term="%22Tural+D%22">Tural D</searchLink>; Department of Medical Oncology, Koc University Medical Faculty, Istanbul, Türkiye.<br /><searchLink fieldCode="AU" term="%22Benedetti+G%22">Benedetti G</searchLink>; U.O. Oncologia, Ospedale Di Civitanova Marche, Civitanova Marche, Italy.<br /><searchLink fieldCode="AU" term="%22Ürün+Y%22">Ürün Y</searchLink>; Department of Medical Oncology, Ankara University Faculty of Medicine, 06620, Ankara, Türkiye.<br /><searchLink fieldCode="AU" term="%22Battelli+N%22">Battelli N</searchLink>; Medical Oncology Unit, Macerata Hospital, Macerata, Italy.<br /><searchLink fieldCode="AU" term="%22Melichar+B%22">Melichar B</searchLink>; Department of Oncology, Faculty of Medicine and Dentistry, Palacký University, Olomouc, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Poprach+A%22">Poprach A</searchLink>; Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, 656 53, Brno, Czech Republic.; Department of Comprehensive Cancer Care, Faculty of Medicine, Masaryk University, 625 00, Brno, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Buchler+T%22">Buchler T</searchLink>; Department of Oncology, Second Faculty of Medicine, Charles University and Motol University Hospital, V Úvalu 84, 150 06, Prague, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Kopecký+J%22">Kopecký J</searchLink>; Department of Oncology, University Hospital in Hradec Králové, Sokolská 581, 50005, Hradec Králové, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Conteduca+V%22">Conteduca V</searchLink>; Unit of Medical Oncology and Biomolecular Therapy, Department of Medical and Surgical Sciences, University of Foggia, Policlinico Riuniti, Foggia, Italy.<br /><searchLink fieldCode="AU" term="%22Monteiro+FSM%22">Monteiro FSM</searchLink>; Latin American Cooperative Oncology Group-LACOG, Porto Alegre, Brazil.; Hospital Sírio-Libanês, Brasília, DF, Brazil.<br /><searchLink fieldCode="AU" term="%22Massari+F%22">Massari F</searchLink>; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria Di Bologna, Bologna, Italy.; Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy.<br /><searchLink fieldCode="AU" term="%22Gupta+S%22">Gupta S</searchLink>; Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.<br /><searchLink fieldCode="AU" term="%22Santoni+M%22">Santoni M</searchLink>; Medical Oncology Unit, Macerata Hospital, Macerata, Italy. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228409970%22">Clinical & experimental metastasis</searchLink> [Clin Exp Metastasis] 2025 Feb 20; Vol. 42 (2), pp. 18. <i>Date of Electronic Publication: </i>2025 Feb 20. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Kluwer+Academic+Publishers%22">Kluwer Academic Publishers </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>8409970 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1573-7276 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2202620898%22">02620898 </searchLink><i>NLM ISO Abbreviation: </i>Clin Exp Metastasis <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39976819 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s10585-025-10335-4 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 18 Titles: – TitleFull: Concomitant medications in patients with metastatic urothelial carcinoma receiving enfortumab vedotin: real-world data from the ARON-2EV study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Fiala O – PersonEntity: Name: NameFull: Buti S – PersonEntity: Name: NameFull: Fujita K – PersonEntity: Name: NameFull: de Liaño AG – PersonEntity: Name: NameFull: Fukuokaya W – PersonEntity: Name: NameFull: Kimura T – PersonEntity: Name: NameFull: Yanagisawa T – PersonEntity: Name: NameFull: Giannatempo P – PersonEntity: Name: NameFull: Angel M – PersonEntity: Name: NameFull: Mennitto A – PersonEntity: Name: NameFull: Molina-Cerrillo J – PersonEntity: Name: NameFull: Bourlon MT – PersonEntity: Name: NameFull: Soares A – PersonEntity: Name: NameFull: Takeshita H – PersonEntity: Name: NameFull: Calabrò F – PersonEntity: Name: NameFull: Ortega C – PersonEntity: Name: NameFull: Kucharz J – PersonEntity: Name: NameFull: Milella M – PersonEntity: Name: NameFull: Seront E – PersonEntity: Name: NameFull: Park SH – PersonEntity: Name: NameFull: Tural D – PersonEntity: Name: NameFull: Benedetti G – PersonEntity: Name: NameFull: Ürün Y – PersonEntity: Name: NameFull: Battelli N – PersonEntity: Name: NameFull: Melichar B – PersonEntity: Name: NameFull: Poprach A – PersonEntity: Name: NameFull: Buchler T – PersonEntity: Name: NameFull: Kopecký J – PersonEntity: Name: NameFull: Conteduca V – PersonEntity: Name: NameFull: Monteiro FSM – PersonEntity: Name: NameFull: Massari F – PersonEntity: Name: NameFull: Gupta S – PersonEntity: Name: NameFull: Santoni M IsPartOfRelationships: – BibEntity: Dates: – D: 20 M: 02 Text: 2025 Feb 20 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1573-7276 Numbering: – Type: volume Value: 42 – Type: issue Value: 2 Titles: – TitleFull: Clinical & experimental metastasis Type: main |
| ResultId | 1 |